EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes

Othman AlOmeir, Ahmad H Alhowail, Syed Imam Rabbani, Syed Mohammed Basheeruddin Asdaq, Rafiulla Gilkaramenthi, Abida Khan, Mohd Imran, Tafadzwa Dzinamarira

Journal of Infection and Public Health · 2025

DOI: 10.1016/j.jiph.2025.102873 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Othman AlOmeir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, COVID-19 Drug Treatment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shaqra University, Northern Border University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedCOVID-19 Drug TreatmentHumansTreatment OutcomeCOVID-19MaleSARS-CoV-2FemaleReceptors, Interleukin-6Middle Aged

Stichwörter der Autor:innen

COVID-19EfficacyMonoclonal antibodySafetyTocilizumab

Substanzen

Antibodies, Monoclonal, HumanizedtocilizumabReceptors, Interleukin-6

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Electronic address: aalhowail@qu.edu.sa.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia. Electronic address: s.rabbani@qu.edu.sa.
  • Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Diriyah, Riyadh 13713, Saudi Arabia; Research Center, Deanship of Scientific Research and Post-Graduate Studies, AlMaarefa University, Diriyah,…
  • Department of Emergency Medical Services, College of Applied Sciences, AlMaarefa University, Diriyah, Riyadh 13713, Saudi Arabia. Electronic address: grafi@mcst.edu.sa.
  • Center For Health Research, Northern Border University, Arar 73213, Saudi Arabia. Electronic address: abeda.mohammed@nbu.edu.sa.

Förderung

  • Shaqra University
  • Northern Border University

Zitieren

APA

AlOmeir, O., Alhowail, A. H., Rabbani, S. I., Asdaq, S. M. B., Gilkaramenthi, R., Khan, A., Imran, M., & Dzinamarira, T. (2025). Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102873

Vancouver

AlOmeir O, Alhowail AH, Rabbani SI, Asdaq SMB, Gilkaramenthi R, Khan A, et al. Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102873

BibTeX
@article{AlOmeir2025,
  author = {AlOmeir, Othman and Alhowail, Ahmad H and Rabbani, Syed Imam and Asdaq, Syed Mohammed Basheeruddin and Gilkaramenthi, Rafiulla and Khan, Abida and Imran, Mohd and Dzinamarira, Tafadzwa},
  title = {Safety and efficacy of tocilizumab in COVID-19: A systematic evaluation of adverse effects and therapeutic outcomes},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  doi = {10.1016/j.jiph.2025.102873}
}
Kostenlos starten →